korlym
(Mifepristone)Corcept Therapeutics Incorporated
Usage: KORLYM (mifepristone) is indicated for controlling hyperglycemia caused by hypercortisolism in adults with endogenous Cushing's syndrome who have type 2 diabetes or glucose intolerance and are not surgical candidates. It is not intended for type 2 diabetes unrelated to Cushing's syndrome.